Joshua S. Prince

Insider Reports History

Location
South San Francisco, CA
Signature
Joshua Prince
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joshua S. Prince:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. Chief Operating Officer Common Stock 15,249 $8,579 $0.5626 31 Dec 2025 Direct
Vistagen Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 100,000 23 Jun 2025 Direct

Insider Reports Filed by Joshua S. Prince

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VTGN Vistagen Therapeutics, Inc. 31 Dec 2025 1 +$2,468 4 Chief Operating Officer 05 Jan 2026, 20:51
VTGN Vistagen Therapeutics, Inc. 30 Jun 2025 1 +$8,299 4 Chief Operating Officer 01 Jul 2025, 17:51
VTGN Vistagen Therapeutics, Inc. 23 Jun 2025 1 $0 4 Chief Operating Officer 25 Jun 2025, 17:15
VTGN Vistagen Therapeutics, Inc. 31 Dec 2024 1 +$8,300 4 Chief Operating Officer 13 Jan 2025, 17:40
VTGN Vistagen Therapeutics, Inc. 28 Jun 2024 1 +$7,901 4 Chief Operating Officer 02 Jul 2024, 18:10
VTGN Vistagen Therapeutics, Inc. 24 Jun 2024 1 $0 4 Chief Operating Officer 26 Jun 2024, 21:29
VTGN Vistagen Therapeutics, Inc. 24 Oct 2023 0 $0 3 Chief Operating Officer 03 Nov 2023, 20:14